SCIO 469 hydrochloride
Cat. No. 3528
Chemical Name: 6-Chloro-5-[[(2R,5S)-4-[(4-fluoroph
Biological ActivitySelective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38α in vitro). Displays approximately 10-fold selectivity for p38α over p38β and 2000-fold selectivity for p38α over 20 other kinases. Reduces p38α phosphorylation in multiple myeloma cells in vitro and in vivo; activity results in decreased tumor burden and angiogenesis in murine models of multiple myeloma. Also enhances bortezomib-induced cytotoxicity against multiple myeloma cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Vanderkerken et al (2007) Inhibition of p38α mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma. Cancer Res. 67 4572. PMID: 17495322.
Giafis et al (2006) Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. Cancer Res. 66 6763. PMID: 16818652.
Hideshima et al (2004) p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells. Oncogene. 23 8766. PMID: 15480425.
If you know of a relevant reference for SCIO 469 hydrochloride please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses SCIO 469 hydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: SCIO 469 hydrochloride, supplier, SCIO469, hydrochloride, p38, MAPK, selective, inhibitors, inhibits, p38a, p38alpha, p38α, multiple, myeloma, Tocris Bioscience, p38 MAPK Inhibitor products
Find multiple products by catalog number
New Products in this Area
High affinity JNK inhibitor; also inhibits HCMV replicationOrg 48762-0
Selective p38α/β inhibitor; orally bioavailable
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.